📰 Philipp Mathieu News
Page 7 - Philipp Mathieu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Philipp Mathieu. Real-time updates on events, politics, business and more.
May 17, 2022
/PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical...
May 16, 2022
LUND, Sweden, May 16, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Natalie...
April 28, 2022
/PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) Net earnings...
April 28, 2022
STOCKHOLM, April 28, 2022 /PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123)Net earnings amounted
April 28, 2022
/PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) Net earnings...
April 21, 2022
LUND, Sweden, April 21, 2022 /PRNewswire/ -- Immunovia will publish its first quarter 2022 results on April 28, 2022 at 8:00 am CET. Analysts, investors and media are invited to a webcast teleconference
April 21, 2022
/PRNewswire/ -- Immunovia will publish its first quarter 2022 results on April 28, 2022 at 8:00 am CET. Analysts, investors and media are invited to a webcast...
April 21, 2022
/PRNewswire/ -- Immunovia will publish its first quarter 2022 results on April 28, 2022 at 8:00 am CET. Analysts, investors and media are invited to a webcast...
April 14, 2022
/PRNewswire/ -- Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), has submitted an application for a Current Procedural...
April 14, 2022
LUND, Sweden, April 14, 2022 /PRNewswire/ -- Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), has submitted an application for a Current Procedural Terminology